Literature DB >> 10389485

[Mitotane treatment in a dog with a recurring adrenocortical carcinoma--a case report].

M Keiser1, M Flückiger, O Gardelle, C Reusch.   

Abstract

In a 7 year old female poodle an adrenocortical tumor was diagnosed on basis of laboratory and ultrasonographic examinations. One year after adrenalectomy, a relapse was diagnosed, at that time the suspicion of metastases in the liver arose for the first time. By treatment with Mitotane in a dose aiming at completely destroying the adrenal cortex, a complete disappearance of the tumor as well as a dramatic reduction of the size of the metastases could be achieved. 12 months after the begin of the chemotherapy, the dog is in good general condition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389485

Source DB:  PubMed          Journal:  Schweiz Arch Tierheilkd        ISSN: 0036-7281            Impact factor:   0.845


  1 in total

1.  Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.

Authors:  C Arenas; C Melián; M D Pérez-Alenza
Journal:  J Vet Intern Med       Date:  2014-02-03       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.